Session Details
[ESY2]Esophagus Symposium 2 Traetment strategy for cT3br/T4 esophageal cancer
Tue. Oct 20, 2026 9:35 AM - 11:05 AM JST
Tue. Oct 20, 2026 12:35 AM - 2:05 AM UTC
Tue. Oct 20, 2026 12:35 AM - 2:05 AM UTC
Room 10 (Swan, 1F, Kyoto International Conference Center)
Chairperson: Takashi Kamei(Department of Surgery, Tohoku Unniversity), Tomoki Makino (Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka)
[ESY2-1]Salvage Robot-Assisted Minimally Invasive Esophagectomy(RAMIE)for T4b Esophageal Cancer
Richard Van Hillegersberg (Department of Surgery University Medical Center Utrecht, Netherlands)
[ESY2-2]Current Treatment Strategy for cT4b Esophageal Cancer in the Immunotherapy Era
Hiroyuki Daiko, Koshiro Ishiyama, Daisuke Kurita, Shota Igaue, Ryuta Kakuta, Kenichi Aratani, Yumiko Hojyo, Shintaro Ikeda, Yasuyuki Seto (National Cancer Center Hospital, Japan)
[ESY2-3]Treatment Strategies Using Immune Checkpoint Inhibitors for cT3b/T4 Esophageal Cancer
Hirotoshi Kikuchi1, Takahiro Kuroda1, Yuki Sakai1, Kenichi Sekimori1, Shunta Nakamura1, Ryoma Haneda1, Wataru Soneda1, Eisuke Booka1, Yoshihiro Hiramatsu2, Hiroya Takeuchi1 (1.Department of Surgery, Hamamatsu University School of Medicine, 2.Department of Perioperative Functioning Care and Support, Hamamatsu University School of Medicine)
[ESY2-4]cT3br/T4 Outcomes and Prospects of Multidisciplinary Treatment for Thoracic Esophageal Cancer
Hiroshi Sato, Yutaka Miyawaki, Yusuke Suzuki, Yutaka Kishimoto, Keita Sato, Shinichi Sakuramoto (Department of Gastroenterological Surgery, Saitama Medical University International Medical Center)
[ESY2-5]Multidisciplinary treatment strategy for unresectable locally invasive esophageal cancer ~ Strategies for selecting regimens aimed at improving resectability~
Koichi Okamoto1, Yasuto Tomita1, Koki Furuse1, Saki Kuwata1, Kaori Maruyama1, Taigo Nagayama1, Akifumi Hashimoto1, Hisashi Nishiki1, Takashi Miyata1, Hideto Fujita1, Noriyuki Inaki2, Hiroyuki Takamura1 (1.Department of General and Digestive Surgery, Kanazawa Medical University, 2.Department of Gastrointestinal Surgery, Kanazawa University)
[ESY2-6]Clinical Outcomes of Nivolumab Combined with Docetaxel, Cisplatin, and 5-Fluorouracil(DCF)Therapy for Unresectable Advanced Esophageal Cancer
Takahito Sugase1, Hiroshi Miyata1, Takashi Kanemura1, Norihiro Matsuura1, Shigeto Nakai2, Takaomi Hagi2, Kotaro Yamashita2, Koji Tanaka2, Tomoki Makino2, Tsuyoshi Takahshi2, Yukinori Kurokawa2, Hidetoshi Eguchi2 (1.Department of Gastroenterological Surgery, Osaka International Cancer Institute, 2.Department of Gastroenterological Surgery, The University of Osaka)
[ESY2-7]Optimization of Treatment Strategies Aiming for Curative Resection in cT3 Borderline Resectable and cT4 Esophageal Cancer
Yasue Kimura, Rena Yokomizo, Yuuki Kubo, Munehide Terashi, Ayako Iwanaga, Kousuke Hirose, Shou Nanbara, Masahiko Sugiyama, Masaru Morita (Department of Gastroenterological Surgery, NHO Kyushu Cancer Center)
[ESY2-8]Treatment Strategies for cT3br/T4 Esophageal Cancer
Shinji Mine, Masahiro Tamura, Asako Ozaki, Takehiro Watanabe, Syusuke Yagi (Department of Esophageal and Gastroenterological Surgery, Juntendo University Hospital)
[ESY2-9]Treatment Strategies for cT3br/cT4 Esophageal Cancer and Conversion Surgery
Takeo Fujita, Kai Nakao, Yusuke Iwabe, Yuto Kubo, Kazuma Sato (Division of Esophageal Surgery, National Cancer Center Hospital East)
